Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

Clinical trial NCT03307785 · COMPLETED

Trial details

NCT number: NCT03307785
Sponsor: Tesaro, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Metastatic Cancer Advanced Cancer Solid Tumor Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Stage IIIB Non Small Cell Lung Cancer

Start date: 2017-10-12
Primary completion: 2020-02-26
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.